Ardelyx, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.5M
Doctors Paid
20,831
Transactions
77,245
2024 Total
$2.6M
Payment Breakdown by Category
Research$2.2M (34.5%)
Consulting$2.0M (31.3%)
Food & Beverage$1.8M (27.0%)
Travel$81,942 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.2M | 1,000 | 34.5% |
| Consulting Fee | $2.0M | 684 | 31.3% |
| Food and Beverage | $1.8M | 75,324 | 27.0% |
| Education | $255,905 | 22 | 3.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,347 | 34 | 1.6% |
| Travel and Lodging | $81,942 | 167 | 1.3% |
| Grant | $21,500 | 14 | 0.3% |
Payments by Type
General
$4.2M
76,245 transactions
Research
$2.2M
1,000 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| STUDY TO EVALUATE THE USE OF TENAPANOR AS CORE THERAPY IN THE TREATMENT OF HYPERPHOSPHATEMIA (OPTIMIZE) | $916,289 | 8 | 494 |
| TEN 01-304 -SAFETY AND EFFICACY PHASE 03 IN 12-18 YEAR OLDS | $550,626 | 1 | 139 |
| A Randomized, Open-Label Study to Evaluate the Use of Tenapanor as the Core Therapy in the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis who are Phosphate Binder Naive or on Phosphate Binder Therapy, to Optimize Phosphorus | $302,206 | 8 | 99 |
| AN OPEN-LABEL LONG-TERM SAFETY STUDY OF TENAPANOR FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN PEDIATRIC PATIENTS 6 TO LESS THAN 18 YEARS OLD | $206,668 | 0 | 60 |
| A Long-Term, Open Label Study to Evaluate the Ability of Tenapanor Alone or in Combination with Sevelamer to Treat to Goal Serum Phosphorus in Patients with End-Stage Renal Disease on Dialysis (NORMALIZE) | $147,680 | 0 | 182 |
| Phase II Dose ranging safety and efficacy studying IBS-C patients 6-12 years old | $86,972 | 0 | 4 |
| TEN-02-402 | $19,757 | 1 | 16 |
| RDX 013-201 | $5,195 | 2 | 2 |
| TEN 02-401 | $1,500 | 0 | 2 |
| TEN 02-402 OPTIMIZE | $599.57 | 1 | 1 |
| TEN 02-402 Optimize | $500.00 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 4
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| German Hernandez, M.d, M.D | Internal Medicine | El Paso, TX | $4,445 | $0 |
| Mrs. Aja Mccutchen, M.d, M.D | Internal Medicine | Winder, GA | $4,378 | $0 |
| Mr. David Leff, Do, DO | Gastroenterology | Mesa, AZ | $4,211 | $0 |
| Dr. V. Subramanian, M.d, M.D | Nephrology | Alexandria, VA | $4,200 | $0 |
| Andrew O'shaughnessy, Md, MD | Nephrology | Fort Wayne, IN | $4,000 | $0 |
| Shanti Eswaran, M.d, M.D | Internal Medicine | Ann Arbor, MI | $3,750 | $0 |
| Dr. Saeed Kronfli, M.d, M.D | Nephrology | Takoma Park, MD | $3,700 | $0 |
| Dr. Jalal Abbas, M.d, M.D | Internal Medicine | Sun City West, AZ | $3,700 | $0 |
| Dr. Jagdeep Obhrai, M.d, M.D | Nephrology | Washington, DC | $3,700 | $0 |
| Jill Deutsch, Md, MD | Gastroenterology | New Haven, CT | $3,608 | $0 |
| Dr. Alexander Goldowsky, Md, MD | Internal Medicine | Boston, MA | $3,375 | $0 |
| Reena Chokshi, Md, MD | Internal Medicine | Houston, TX | $3,375 | $0 |
| Ms. Amy Mosman, Mms, Pa-C, MMS, PA-C | Medical | Saint Louis, MO | $3,373 | $0 |
| Dr. Frank Lester, M.d, M.D | Cardiovascular Disease | Mobile, AL | $3,250 | $0 |
| Fred Fowler, M.d, M.D | Gastroenterology | Charlotte, NC | $3,096 | $0 |
| Asma Khapra | Gastroenterology | Fairfax, VA | $2,875 | $0 |
| Brennan Spiegel, Md, MD | Gastroenterology | Los Angeles, CA | $2,858 | $0 |
| Dr. Housein Wazaz, M.d, M.D | Gastroenterology | Meriden, CT | $2,815 | $0 |
| Lin Chang, Md, MD | Gastroenterology | Los Angeles, CA | $2,733 | $0 |
| Arnold Silva, Md, Phd, MD, PHD | Internal Medicine | Meridian, ID | $2,668 | $0 |
| Dr. Douglas Drossman, Md, MD | Gastroenterology | Durham, NC | $2,547 | $0 |
| Dr. Hetal Karsan, Md, MD | Gastroenterology | Atlanta, GA | $2,484 | $0 |
| Dr. Marc Sonenshine, Md, MD | Gastroenterology | Atlanta, GA | $2,474 | $0 |
| Alireza Tabesh, Md, MD | Gastroenterology | Los Angeles, CA | $2,416 | $0 |
| Mikhail Alper, Pa, PA | Physician Assistant | Madera, CA | $2,377 | $0 |
Ad
Top Products
- IBSRELA $3.7M
- XPHOZAH 30 MG $368,775
Associated Products (2)
- IBSRELA $3.7M
- XPHOZAH 30 MG $368,775
Payment Categories
- Food & Beverage $1.8M
- Consulting $2.0M
- Travel & Lodging $81,942
- Research $2.2M
About Ardelyx, Inc.
Ardelyx, Inc. has made $6.5M in payments to 20,831 healthcare providers, recorded across 77,245 transactions in the CMS Open Payments database. In 2024, the company paid $2.6M. The top product by payment volume is IBSRELA ($3.7M).
Payments were distributed across 155 medical specialties. The top specialty by payment amount is Gastroenterology ($1.1M to 4,368 doctors).
Payment categories include: Food & Beverage ($1.8M), Consulting ($2.0M), Research ($2.2M), Travel & Lodging ($81,942).
Ardelyx, Inc. is associated with 2 products in the CMS Open Payments database.